Ansell SM - Search Results

1

Role of Microenvironment in Non-Hodgkin Lymphoma: Understanding the Composition and Biology.

Khurana A, Ansell SM. Khurana A, et al. Among authors: ansell sm. Cancer J. 2020 May/Jun;26(3):206-216. doi: 10.1097/PPO.0000000000000446. Cancer J. 2020. PMID: 32496454 Review.

2

Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphoma.

Ansell SM, Ristow KM, Habermann TM, Wiseman GA, Witzig TE. Ansell SM, et al. J Clin Oncol. 2002 Sep 15;20(18):3885-90. doi: 10.1200/JCO.2002.10.143. J Clin Oncol. 2002. PMID: 12228209

3

Antibody therapy for non-Hodgkin's lymphoma.

Ansell SM. Ansell SM. Curr Opin Mol Ther. 2004 Apr;6(2):175-81. Curr Opin Mol Ther. 2004. PMID: 15195930

4

Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome.

Novak AJ, Grote DM, Stenson M, Ziesmer SC, Witzig TE, Habermann TM, Harder B, Ristow KM, Bram RJ, Jelinek DF, Gross JA, Ansell SM. Novak AJ, et al. Among authors: ansell sm. Blood. 2004 Oct 15;104(8):2247-53. doi: 10.1182/blood-2004-02-0762. Epub 2004 Jul 13. Blood. 2004. PMID: 15251985 Free article.

5

Non-Hodgkin lymphoma: diagnosis and treatment.

Ansell SM, Armitage J. Ansell SM, et al. Mayo Clin Proc. 2005 Aug;80(8):1087-97. doi: 10.4065/80.8.1087. Mayo Clin Proc. 2005. PMID: 16092591 Review.

6

The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma.

Yoong Y, Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Litzow MR, Gertz MA, Lacy MQ, Dispenzieri A, Gastineau DA, Tefferi A, Elliott M, Snow DS, Hogan WJ, Markovic SN. Yoong Y, et al. Among authors: ansell sm. Leuk Lymphoma. 2005 Sep;46(9):1287-94. doi: 10.1080/10428190500126380. Leuk Lymphoma. 2005. PMID: 16109605

7

Management of Hodgkin lymphoma.

Ansell SM, Armitage JO. Ansell SM, et al. Mayo Clin Proc. 2006 Mar;81(3):419-26. doi: 10.4065/81.3.419. Mayo Clin Proc. 2006. PMID: 16529147 Review.

8

Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma.

Holtan SG, Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Litzow MR, Gastineau DA, Markovic SN. Holtan SG, et al. Among authors: ansell sm. Br J Haematol. 2006 Jun;133(6):628-33. doi: 10.1111/j.1365-2141.2006.06088.x. Br J Haematol. 2006. PMID: 16704437 Free PMC article.

9

Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma.

Yang ZZ, Novak AJ, Ziesmer SC, Witzig TE, Ansell SM. Yang ZZ, et al. Among authors: ansell sm. Cancer Res. 2006 Oct 15;66(20):10145-52. doi: 10.1158/0008-5472.CAN-06-1822. Cancer Res. 2006. PMID: 17047079 Free PMC article.

10

Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin's lymphoma patients.

Ansell SM, Geyer SM, Maurer MJ, Kurtin PJ, Micallef IN, Stella P, Etzell P, Novak AJ, Erlichman C, Witzig TE. Ansell SM, et al. Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6056-63. doi: 10.1158/1078-0432.CCR-06-1245. Clin Cancer Res. 2006. PMID: 17062681 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

588 results

Search Page

Filters